Form 4: Medtronic Executive Jennifer M. Kirk Sells Shares to Cover Taxes

Sentiment:

SEC Form 4 Filing


Medtronic's Chief Accounting Officer, Jennifer M. Kirk, sold shares to cover taxes upon the vesting of restricted stock units.

Summary

  • Jennifer M. Kirk, Chief Accounting Officer at Medtronic, sold 646 ordinary shares on December 6, 2024.
  • The sale was executed at a price of $84.01 per share.
  • The shares were sold to cover tax obligations related to the vesting of restricted stock units.
  • This transaction also included 153 units acquired through dividend reinvestment since the last report.

Sentiment

Score: 5

Explanation: The document describes a routine transaction related to executive compensation, which is neither positive nor negative for the company's overall performance.

Industry Context

This is a routine transaction related to executive compensation and is common in publicly traded companies.

Comparison to Industry Standards

  • Executive stock sales to cover taxes are a standard practice across publicly traded companies.
  • The number of shares sold and the price are within the typical range for such transactions.
  • Similar transactions are regularly reported by executives at comparable companies such as Johnson & Johnson and Abbott Laboratories.

Stakeholder Impact

  • The transaction has a minimal impact on shareholders as it is a routine sale of shares by an executive.

Key Dates

DateDescription
2024-12-06Date of share sale by Jennifer M. Kirk.
2024-12-10Date of filing of the transaction report.

Keywords

Medtronic, share sale, executive, stock units, tax obligations, dividend reinvestment

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.